Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -12.47 Million AUD | -27.19% |
| 2022 | -9.8 Million AUD | -62.78% |
| 2021 | -6.02 Million AUD | -12.32% |
| 2020 | -5.36 Million AUD | -56.27% |
| 2019 | -3.43 Million AUD | 58.84% |
| 2018 | -8.34 Million AUD | -7.0% |
| 2017 | -7.79 Million AUD | 37.21% |
| 2016 | -12.41 Million AUD | -182.07% |
| 2015 | -4.4 Million AUD | -74.99% |
| 2014 | -2.51 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | -12.47 Million AUD | -27.19% |
| 2023 Q2 | -3.84 Million AUD | 0.0% |
| 2023 Q1 | -3.84 Million AUD | -89.85% |
| 2023 Q4 | -2.39 Million AUD | 0.0% |
| 2023 Q3 | -2.39 Million AUD | 37.64% |
| 2022 Q4 | -2.02 Million AUD | 0.0% |
| 2022 FY | -9.8 Million AUD | -62.78% |
| 2022 Q3 | -2.02 Million AUD | 29.74% |
| 2022 Q2 | -2.88 Million AUD | 0.0% |
| 2022 Q1 | -2.88 Million AUD | -25.92% |
| 2021 Q3 | -2.28 Million AUD | -215.43% |
| 2021 Q4 | -2.28 Million AUD | 0.0% |
| 2021 FY | -6.02 Million AUD | -12.32% |
| 2021 Q2 | -725.11 Thousand AUD | 0.0% |
| 2021 Q1 | -725.11 Thousand AUD | 60.0% |
| 2020 Q1 | -869.24 Thousand AUD | 28.92% |
| 2020 Q2 | -869.24 Thousand AUD | 0.0% |
| 2020 Q4 | -1.81 Million AUD | 0.0% |
| 2020 FY | -5.36 Million AUD | -56.27% |
| 2020 Q3 | -1.81 Million AUD | -108.54% |
| 2019 Q1 | -493.34 Thousand AUD | 76.06% |
| 2019 FY | -3.43 Million AUD | 58.84% |
| 2019 Q3 | -1.22 Million AUD | -147.88% |
| 2019 Q2 | -493.34 Thousand AUD | 0.0% |
| 2019 Q4 | -1.22 Million AUD | 0.0% |
| 2018 Q2 | -2.1 Million AUD | 0.0% |
| 2018 FY | -8.34 Million AUD | -7.0% |
| 2018 Q3 | -2.06 Million AUD | 2.32% |
| 2018 Q1 | -2.1 Million AUD | -15.83% |
| 2018 Q4 | -2.06 Million AUD | 0.0% |
| 2017 FY | -7.79 Million AUD | 37.21% |
| 2017 Q3 | -1.82 Million AUD | 12.28% |
| 2017 Q4 | -1.82 Million AUD | 0.0% |
| 2017 Q2 | -2.07 Million AUD | 0.0% |
| 2017 Q1 | -2.07 Million AUD | 0.0% |
| 2016 FY | -12.41 Million AUD | -182.07% |
| 2015 FY | -4.4 Million AUD | -74.99% |
| 2014 FY | -2.51 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -784.675% |
| Arrayit Corporation | -3.31 Million USD | -276.22% |
| Atlantic International Corp. | -5.62 Million USD | -121.656% |
| Biocept, Inc. | -32.08 Million USD | 61.125% |
| Bioqual, Inc. | 483.48 Thousand USD | 2680.022% |
| CardioGenics Holdings Inc | -1.91 Million USD | -550.929% |
| DermTech, Inc. | -100.88 Million USD | 87.636% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.616% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 42.236% |
| iMD Companies, Inc. | -200.63 Thousand USD | -6117.187% |
| IDenta Corp. | 14.64 Thousand USD | 85281.071% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 1655.351% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 32341.505% |
| InVitro International | 1553.00 USD | 803314.166% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -45.181% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -21365.301% |
| Medical Imaging Corp. | -3.02 Million USD | -312.63% |
| NovelStem International Corp. | -4.18 Million USD | -197.899% |
| Optigenex Inc. | -2.89 Million USD | -330.468% |
| PharmChem, Inc. | 845.1 Thousand USD | 1576.025% |
| Proteome Sciences plc | -2.44 Million USD | -410.598% |
| Response Genetics, Inc | -20.18 Million USD | 38.199% |
| Rennova Health, Inc. | -3.29 Million USD | -278.795% |
| RushNet, Inc. | -607.02 Thousand USD | -1954.916% |
| ScreenPro Security Inc. | -2.24 Million USD | -454.7% |
| Stella Diagnostics Inc. | -5.7 Million USD | -118.556% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -9.273% |
| Todos Medical Ltd. | -24.99 Million USD | 50.092% |